ArticleJournal of pharmacy & bioallied sciences2024

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir in Treating HCV Genotypes 1 and 4 in Patients with Advanced Chronic Kidney Disease.

Badr M AljarallahPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.